The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Home > Documents > Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 24 September 2024
Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 24 September 2024